Skip to main content

Table 2 Serum levels of 1,5-AG and AF-AGEs at pre-HD and post-HD

From: Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis

Metabolites Patients undergoing HD (N = 29)
1,5-AG (μg/mL)  
Pre-HD 1.44 ± 0.37
Post-HD aND
AF-AGEs (U/mL)  
Pre-HD 21.4 ± 9.32
Post-HD 22.7 ± 12.7
Niacin, pre-HD (μg/mL) 5.02 ± 0.71
Glycoalbumin, pre-HD (%) 19.2 ± 8.5
  1. aND, not detectable: less than 1.0 μg/mL. Changes in serum concentrations before and after dialysis were measured in 29 patients who provided consent. The 1,5-AG values after dialysis were lower than the measurement sensitivity in all 29 patients. The mean values for AF-AGEs did not significantly differ at before and after dialysis